The Latest Cardiac and Vascular News
BRAINTREE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc., a Boston-based commercial-stage medical device company, announced today, a successful series of clinical use, of the Paragonix SherpaPak™ Cardiac Transport System (CTS) at a leading Boston-based hospital and other world-renowned transplant centers in the United States and in Europe. The Paragonix SherpaPak™ CTS1,2 is intended for […]
ALAMEDA, Calif. – September 4, 2018 – Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced it has closed on the acquisition of a controlling interest in its joint venture, MVI Health Inc. After closing the transaction, Penumbra increased its ownership to 90 percent of […]
ALAMEDA, Calif. – September 4, 2018 – Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.S. commercial availability of the Penumbra System’s most advanced technology: Penumbra JET 7 and Penumbra JET D Reperfusion Catheters powered by the Penumbra ENGINE aspiration source. All are part […]
LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, welcomes the recently updated interventional procedures guidance for sutureless aortic valve replacement issued by the U.K. National Institute for Health and Care Excellence (NICE), which states that sutureless aortic valve replacement is an alternative to conventional surgical aortic valve replacement. The […]
SANTA CLARA, Calif.–(BUSINESS WIRE)–Ancora Heart, Inc., a company developing a novel therapy to address heart failure, today announced the company’s key activities at the 30th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation in San Diego. Interim data will be presented from the recently expanded […]
BRISBANE, Australia & CARLSBAD, Calif.–(BUSINESS WIRE)–ImpediMed Limited (ASX: IPD), a global provider of medical technology to non-invasively measure, monitor and manage tissue composition and fluid status using bioimpedance spectroscopy (BIS), announces that two abstracts demonstrating utilization of its SOZO® device will be presented during poster presentations by A.J. Accardi, M.D. at the upcoming American […]
MINNEAPOLIS, Sept. 10, 2018 /PRNewswire/ — 4C Medical Technologies, Inc. (4C Medical), a privately-held medical technology company focused on the development of minimally invasive therapies for structural heart disease, today announced that it completed a private placement of shares of its Series A Preferred Stock earlier this week, resulting in total gross proceeds […]
SANTA ROSA, Calif., Sept. 10, 2018 /PRNewswire/ — Millipede, Inc., a medical device company leading the way in adding to the structural heart toolbox for the interventional cardiologist, has successfully treated two patients utilizing its latest-generation delivery system which incorporates a fully integrated intracardiac echocardiography (ICE) catheter. The catheter was designed to […]
(GLOBE NEWSWIRE via COMTEX) —The Onyx ONE Clear Study Builds Upon Body of Clinical Evidence to Inform Individualized DAPT Duration Following Stent Procedures DUBLIN – September 10, 2018 – Medtronic plc (NYSE:MDT) today announced the start of the Onyx ONE Clear Study in the U.S. and Japan that will evaluate one-month […]
(GLOBE NEWSWIRE via COMTEX) –DUBLIN – September 4, 2018 – Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the Morgan Stanley 16th Annual Global Healthcare Conference on Friday, September 14, 2018, in New York City. Karen Parkhill, executive vice president and chief financial officer […]
